News Detail
Mumbai, 31 Oct 2023: Qiagen, a Netherlands-based holding company, announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays for blood-borne virus (BBV) testing has received Central Drugs Standar......
View Details
Source : Pharmabiz
Qiagen
NeuMoDx
human immunodeficiency virus
HIV-1
hepatitis B virus
HBV
HCV
blood-borne virus
BBV
CDSCO
CE-IVD tests
Related News
- Accused of corruption, Drug inspector Shamli suspended (30-12-2024)
- Four fake doctors arrested for illegally practicing medicine in Telangana (30-12-2024)
- Two arrested for selling banned narcotic tablets in Raipur (30-12-2024)
- 573 Seizures conducted for breaches of Various Acts in Telangana in 2024 (30-12-2024)
- Amit Agrawal takes charge as Secretary of DoP (30-12-2024)
- 141 acres land allocated to set up Pharma park in Naya Raipur (30-12-2024)
- 2 women lose lives to fraudulent meds given by quacks (30-12-2024)
- Reverting cancer cells to normal cells: Research (30-12-2024)
- Probe reveals how fake companies are flooding market with medicines with no API (30-12-2024)
- UP gets pharma investment of Rs 28,000 crore (30-12-2024)